Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179882 | SCV000232199 | uncertain significance | not provided | 2014-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000179882 | SCV001063262 | likely benign | not provided | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002515284 | SCV003702985 | uncertain significance | Inborn genetic diseases | 2024-10-20 | criteria provided, single submitter | clinical testing | The c.3957C>A (p.H1319Q) alteration is located in exon 7 (coding exon 6) of the VCAN gene. This alteration results from a C to A substitution at nucleotide position 3957, causing the histidine (H) at amino acid position 1319 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |